MANE: Veradermics, Incorporated
Performance
MANE +281.32%
Watchlist
Select an item
Summary
MANE at a glance
MANE returned +281.32% since Feb 4, 2026. Its worst drop since then was -24.84%, smaller than 70% of stocks on Redstone, and its Sharpe ratio of 2.30 beats 99% of stocks on Redstone. It hasn't paid a dividend since it listed.
Current Drawdown
0.00%
Rolling Volatility
79.17%
Actions
Metrics
Risk Indicators*
Alpha199.36%
Beta1.11x
Sharpe2.30
Sortino4.57
Omega1.55
Calmar11.32
Martin17.15
Profile
About MANE
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $6.0B
- Listed
- Feb 2026
- Employees
- 21
- Headquarters
- New Haven, CT
- Website
- veradermics.com
Comparisons